Apellis Pharmaceuticals Inc (NAS:APLS)
$ 28.075 -0.485 (-1.7%) Market Cap: 3.49 Bil Enterprise Value: 3.59 Bil PE Ratio: 0 PB Ratio: 12.94 GF Score: 42/100

Apellis Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 07, 2022 / 02:40PM GMT
Release Date Price: $47.52 (+1.37%)
Operator

(Operator Instructions) At this time, it is my pleasure to turn the program over to your host, Tazeen Ahmad.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Okay. Great. Good morning, everybody, and thanks for joining us again at our Bank of America Virtual Biotech Conference. Our next presenting company is Apellis. And we have several members from the management team here with me on this webcast for the next 30 minutes or so. I think everybody knows Cedric and Tim, but I also wanted to also introduce David Acheson, who handles a lot of the commercial responsibilities at the company.

David, welcome. Thanks for joining us. As well as our standard bearer Cedric and Tim. So we only have 30 minutes today. So I figure we should just probably go straight into Q&A.

Questions & Answers

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

So Cedric, you have this pretty uneventful boring application for GA

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot